AVX Releases New Vertical, Poke-Home, Wire-to-Board Connectors for Discrete 18–22AWG Wire
Dec 15, 2017 14:30 pm UTC| Business
FOUNTAIN INN, S.C., Dec. 15, 2017 -- AVX Corporation, a leading manufacturer and supplier of passive components and interconnect solutions, has extended its range of vertical wire-to-board (WTB) connector solutions with...
Mechel Reports Signing Protocol of Intent With Kyrgyzstan’s Kyrgyz Temir Zholu
Dec 15, 2017 14:20 pm UTC| Business
MOSCOW, Dec. 15, 2017 -- Mechel PAO (MOEX:MTLR) (NYSE:MTL), one of the leading Russian mining and metals companies, reports signing a protocol of intent on development of ties between Mechel-Steel Management Company OOO...
Dec 15, 2017 14:21 pm UTC| Business
NEW YORK, Dec. 15, 2017 -- The global CSP market is expected to witness a CAGR of 15.3%, and is projected to reach USD 14,755 million by 2023. Factors propelling the growth of the concentrated solar power market are:...
Dec 15, 2017 14:19 pm UTC| Business
BRYN MAWR, Pa., Dec. 15, 2017 -- Bryn Mawr Bank Corporation (NASDAQ:BMTC) (the “Corporation”), parent of The Bryn Mawr Trust Company (”BMT”), has announced the expansion of their management team and appoints Kevin Tylus...
Polydex Pharmaceuticals Ltd. Reports 3rd Quarter Financial Results
Dec 15, 2017 14:20 pm UTC| Business
TORONTO, Dec. 15, 2017 -- Polydex Pharmaceuticals Limited (OTC Pink:POLXF) is pleased to provide 3rd quarter financial results. Overcoming sales and production challenges, the Order Book remains robust and strong sales...
Goldrea Signs LOI with Tabu Equity Investments
Dec 15, 2017 14:15 pm UTC| Business
VANCOUVER, British Columbia, Dec. 15, 2017 -- Goldrea Resources Corp. (“Goldrea” or the “Company”) (CSE:GOR) (Frankfurt:GOJ) (Pink Sheets:GORAF) has signed a non-binding letter of intent to acquire Tabu Equity...
Global Blood Therapeutics Prices a $100.0 Million Common Stock Public Offering
Dec 15, 2017 14:03 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Dec. 15, 2017 -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT), a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to...